Your Menu Was Designed for Customers Who No Longer Exist

Ozempic didn't break your restaurant. Your 2015 menu assumptions did. GLP-1 medications just made it impossible to ignore. Let's be honest. The triple-stacked burger, the bottomless pasta bowl, the "sharing platter" that no sane person shares, these weren't born from culinary vision. They were born from one brutally simple insight: people eat more than they think, and restaurants that figured out how to sell "more" made more money.

That assumption is currently sitting in a doctor's office getting a weekly injection. And it's not coming back.

GLP-1 medications.... Ozempic, Wegovy, Mounjaro, are doing something no wellness campaign, diet book, or "have you tried just eating less?" lecture ever managed to do. They're changing how people actually eat. In your dining room. At your tables. On your receipts. And the operators who are still designing menus around 2015 consumer behavior are solving the wrong problem with the wrong math.

What GLP-1 guests actually do differently

This isn't about a "health trend." GLP-1 users experience measurable, physiological changes in appetite, portion tolerance, and food preferences. Here's what that looks like at the table:

If your model depends on the extra drink, the side upgrade, and the dessert upsell to make the math work, this is not a small shift. It's a structural change in check average mechanics.

What this looks like in practice — by format

This plays out differently depending on where you operate. Here's the real-world translation:

The pizza problem (it's actually an opportunity)

Let's spend a moment here because pizza operators are going to feel this hardest — and have the most to gain if they move first.

Pizza is culturally the highest-carb, highest-volume format in casual dining. A GLP-1 guest who used to eat half a pizza now eats two slices and is genuinely, physically done. You just lost half your food cost, but also half your cover revenue if you're still pricing for consumption.

The move isn't to stop being a pizza restaurant. The move is to stop charging for volume and start charging for experience. A smaller, premium personal pizza at a strong price point. A protein-loaded topping upgrade. A cauliflower or chickpea crust option as a genuine premium — not a "health tax" afterthought. A beverage program built around functional drinks instead of just sodas.

"The guest who eats two slices and leaves satisfied is more valuable than the one who finishes the pie and feels terrible. You just have to price the menu like you believe that."

The uncomfortable math — and why it might actually help you

Here's the irony that most operators miss in the panic: oversized portions were never actually good for you.

GLP-1 guests are effectively paying you to stop over-serving and start serving smarter — if you're willing to listen. The operators who reframe this as a design opportunity rather than a revenue threat are going to eat the operators who don't. (Pun fully intended.)

What to build toward

You don't need to rebrand as a wellness concept. You don't need matcha lattes and a "macro-balanced" menu. You need a smarter architecture:

The question is no longer whether GLP-1 medications will influence restaurant behavior. Eleven million Americans are currently on these drugs. That number is heading to 30 million by the end of the decade. The question is how quickly you redesign your menu, your pricing, and your operations around the guest who is already sitting in front of you.

The restaurants still designing menus for 2015 are solving the wrong problem. The ones who move now have a genuine first-mover advantage, in a category where being first actually matters. Let's rebuild your menu for the next decade

I work with founders, operators, and investors on menu engineering, operating systems, and EBITDA expansion for modern restaurant brands. If your concept is navigating shifting consumer behavior and you want a clear plan, let's talk.

BOOK A STRATEGY CALL